HIT Consultant
JANUARY 14, 2022
. – Existing Verana Health investors GV (formerly Google Ventures), Casdin Capital , and Brook Byers also joined the round, as well as notable new investors, including the Merck Global Health Innovation Fund , THVC , and Breyer Capital. Empowering Physicians & Life Science Companies. Expansion Plans.
HIT Consultant
JULY 19, 2023
To help tackle this inequality, gen-t and Omica.bio chose to partner with Lifebit – a leader in secure technology for biomedical research – to ensure the data they are collecting can be accessed, ethically and securely, for life sciences research. In Mexico, Omica.bio is leading a revolution in ethical biotechnology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cloud Blogs
MAY 18, 2021
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The fragmentation of health data" , Travis May, Medium, July 31, 2018.
HIT Consultant
OCTOBER 20, 2023
What You Should Know: Gero , a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence.
HIT Consultant
SEPTEMBER 12, 2022
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. to advance research and increase equitable access to clinical trials by contributing de-identified data to the LHN. A Comprehensive Multiomics Platform for the Early Detection of Cancer.
Expert insights. Personalized for you.
98 
Let's personalize your content